Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
Izabela Zakrocka(Medical University of Lublin), Waldemar A. Turski(Medical University of Lublin), Katarzyna M. Targowska‐Duda(Medical University of Lublin), Artur Wnorowski(Medical University of Lublin), Tomasz Kocki(Medical University of Lublin), Krzysztof Jóźwiak(Medical University of Lublin)
Cited by 36
Related Papers
Kynurenine pathway in kidney diseases
|Pharmacological Reports|2021|53
Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease
|Therapeutic Advances in Gastroenterology|2019|42
Matrix metalloproteinases and atherosclerosis
|Postępy Higieny i Medycyny Doświadczalnej|2011|34
Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive rats
|European Journal of Pharmacology|2014|26
Kynurenic acid selectively reduces heart rate in spontaneously hypertensive rats
|Naunyn-Schmiedeberg s Archives of Pharmacology|2019|18